Toxicokinetics in preclinical evaluation

被引:29
作者
Baldrick, P [1 ]
机构
[1] Consultancy & Regulatory Serv, Covance Labs, Harrogate, England
关键词
D O I
10.1016/S1359-6446(02)02568-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Toxicokinetic evaluation is both a regulatory and scientific requirement in the drug development process. However, as a fairly new term, its use within the industry is still confused. Toxicokinetics is the generation of kinetic data to assess systemic exposure, either as an integral component of preclinical toxicity studies, or in specially designed supportive studies. These data help to understand the relationship between observed toxicity and administered dose. They also play a role in the clinical setting, assisting in the setting of plasma limits for early human exposure and in the calculation of safety margins.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 29 条
[1]  
[Anonymous], CPMPICH38695
[2]  
[Anonymous], DRUG INF J
[3]  
[Anonymous], 2001, CPMP/ICH/539/00
[4]  
[Anonymous], 1995, CPMPICH38495
[5]   Pharmaceutical excipient development: The need for preclinical guidance [J].
Baldrick, P .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2000, 32 (02) :210-218
[6]  
Clarke D. O., 2001, Neurotoxicology and Teratology, V23, P294
[7]   CONCOMITANT TOXICOKINETICS - TECHNIQUES FOR AND INTERPRETATION OF EXPOSURE DATA OBTAINED DURING THE CONDUCT OF TOXICOLOGY STUDIES [J].
DAHLEM, AM ;
ALLERHEILIGEN, SR ;
VODICNIK, MJ .
TOXICOLOGIC PATHOLOGY, 1995, 23 (02) :170-178
[8]  
DeGeorge JJ, 1998, CANCER CHEMOTH PHARM, V41, P173
[9]   FOOD-AND-DRUG-ADMINISTRATION VIEWPOINTS ON TOXICOKINETICS - THE VIEW FROM REVIEW [J].
DEGEORGE, JJ .
TOXICOLOGIC PATHOLOGY, 1995, 23 (02) :220-225
[10]  
EMA J, 2001, CPMPICH271199